ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 119875 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 119875; 2) Community: the network communities that were significantly associated with the response to NSC 119875; 3) Molecule: the relationships between components within communities and NSC 119875; 4) MDR: the compounds that were significantly associated with the NSC 119875.

NSC Compound Enrichment Correlation
NSC 294980 N,N-Bis(2-chloroethyl)-p-toluidine 0.0220039422291538 0.66287964
NSC 302991 Camptothecin Derivative 0.0220039422291538 0.56280804
NSC 305799 2,4-Quinazolinediamine, 6-[[4-(dimethylamino)phenyl]thio]- 0.0220039422291538 0.40846224
NSC 335794 1-Piperazinecarbothioic acid, 4-(2-pyridinyl)-, [1-(2-pyridinyl)butylidene]hydrazide 0.0220039422291538 0.033758609
NSC 352122 Trimetrexate glucuronate 0.0220039422291538 0.43750312
NSC 363143 Stannane, dichlorodiphenyl-, compd. with 1,4,7,10,13,16-hexaoxacyclooctadecane (1:1) 0.0220039422291538 0.088874577
NSC 364830 Camptothecin Derivative 0.0220039422291538 0.62516416
NSC 376265 Piperazine-1-carbothioic acid, 4-cycloheptyl-, [1-(2-pyridyl)ethylidene]hydrazide 0.0220039422291538 0.23787889
NSC 49488 Null 0.0220039422291538 0.48566381
NSC 623436 TGF.alpha.-PE40 0.0220039422291538 -0.2251163
Total:76  Current:35    [First] [Prev] [Next] [Last]